Author Archives: admin

The Weekly Summary

April 17th – April 23rd                                 2017 In general news, Paris suffered yet another radical Islamic attack when a man shot and killed a police officer.

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

April 10th – April 16th                                 2017 In general news, the Trump administration accused Russia of being complicit with the Syrian

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

April 3rd – April 9th                                 2017 In general news, Syria and Russia’s military teamed up to unleashed nerve gas attacks on rebels, which provoked President Trump into launching 59 cruise missiles to bomb the airbase.

Posted in - The Weekly Summary | Leave a comment

The Healthcare Channel hits 10

 February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming

Posted in - Opinion | 1 Comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

An emerging safety problem for TAVR patients

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement (TAVR) valve. The products have been approved by the FDA for several years, … Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

The Weekly Summary

March 27th – April 2nd                                 2017 In general news, the new UK Prime Minister addressed Parliament to officially announce

Posted in - The Weekly Summary | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | 1 Comment

The Weekly Summary

March 20th – March 26th                                 2017 In general news, another Muslim terrorist in London drove a car onto the pedestrian sidewalk

Posted in - The Weekly Summary | Leave a comment

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

The Weekly Summary

March 13th – March 19th                                 2017 In general news, the national news hyped a Blizzard for the Northeast that never materialized.

Posted in - The Weekly Summary | Leave a comment

The Lotus TAVR valve recall

March 16, 2017- produced and interviewed by Steven E. Greer, MD We interviewed William O’Neill, MD, one of the first to implant a Transcatheter Aortic Valve Replacement

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band,

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

The Weekly Summary

March 6th – March 12th                                 2017                In general news, South Korea’s President was impeached. “Towergate” seems to have backfired

Posted in - The Weekly Summary | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - Generics, FDA | Leave a comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez,

Posted in - Policy, NYU, Plastic surgery | Leave a comment

Vagal nerve stimulation for weight loss

January 22, 2015- Interviewed by Steven E. Greer, MD Erik Dutson, MD, bariatric surgeon from UCLA, discusses the newly FDA-approved weight loss device called

Posted in - Medical Devices, Bariatric surgery, Diabetes and endocrinology, Gastroenterology and liver, Primary care medicine, UCLA | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the

Posted in - Policy, FDA | 1 Comment